EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Notch1 and Major Vault Proteins Modulate Temozolomide Resistance in Glioblastoma

Cengiz Tuncer iD, Ceyhan Hacioglu iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Cengiz Tuncer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Neurosurgery, Düzce University, Düzce, Turkey. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Drug Resistance, Neoplasm, Vault Ribonucleoprotein Particles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of resistance to chemotherapy in the case of aggressive glioblastoma multiforme (GBM) presents a significant treatment challenge. Dysregulation of the Notch signalling pathway promotes tumour proliferation in GBM cells. This study was that targeting the Notch signalling pathway could be a potential therapeutic approach for GBM. Initially, temozolomide‐(TMZ)‐resistant GBM cells were generated, and the effect of Notch1 on the expression of multiple resistance proteins within these cells was investigated. Subsequently, the expression of Notch‐1 in GBM cells was reduced using siRNA. Results revealed a significant reduction in TMZ sensitivity in TMZ‐resistant GBM cells, accompanied by a substantial increase in the expression of major vault protein‐(MVP), O6‐methylguanine‐DNA‐methyltransferase‐(MGMT), and ATP‐binding‐cassette transporter‐G2‐(ABCG2). Furthermore, TMZ‐resistant U87‐R and U251‐R cells exhibited higher proliferation rates compared to their parental control cells (U87 and U251). Additionally, we observed that downregulating Notch‐1 signalling inhibited the proliferation of TMZ‐resistant U87‐R and U251‐R cells. This downregulation led to the inactivation of MGMT, ABCG2, and MVP. Importantly, it increased chemosensitivity to TMZ, particularly by downregulating MVP expression. Consequently, Notch1 could serve as a potential therapeutic target for GBM cells and may be effective in preventing TMZ resistance by targeting MVP, as well as MGMT and ABCG2 in GBM cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaDrug Resistance, NeoplasmVault Ribonucleoprotein ParticlesReceptor, Notch1Brain NeoplasmsHumansCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticSignal TransductionATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm ProteinsAntineoplastic Agents, AlkylatingDNA Modification MethylasesTumor Suppressor ProteinsDNA Repair EnzymesMajor Vault Protein

Stichwörter der Autor:innen

glioblastoma multiformemajor vault proteinnotchtemozolomide

Substanzen

TemozolomideVault Ribonucleoprotein ParticlesReceptor, Notch1ATP Binding Cassette Transporter, Subfamily G, Member 2Neoplasm ProteinsAntineoplastic Agents, AlkylatingDNA Modification MethylasesTumor Suppressor ProteinsDNA Repair EnzymesMajor Vault Protein

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Neurosurgery, Düzce University, Düzce, Turkey.
  • Faculty of Medicine, Department of Medical Biochemistry, Düzce University, Düzce, Turkey.
  • Faculty of Pharmacy, Department of Biochemistry, Düzce University, Düzce, Turkey.

ORCID-Profile: Cengiz Tuncer, Ceyhan Hacioglu

Zitieren

APA

Tuncer, C., & Hacioglu, C. (2025). Notch1 and Major Vault Proteins Modulate Temozolomide Resistance in Glioblastoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70474

Vancouver

Tuncer C, Hacioglu C. Notch1 and Major Vault Proteins Modulate Temozolomide Resistance in Glioblastoma. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70474

BibTeX
@article{Tuncer2025,
  author = {Tuncer, Cengiz and Hacioglu, Ceyhan},
  title = {Notch1 and Major Vault Proteins Modulate Temozolomide Resistance in Glioblastoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70474}
}
Kostenlos starten →